MAPT and Cerebral ischemia: Despite very scarce evidence, the current research on hydrogen in the treatment of cerebral ischemia with reperfusion seems interesting and promising for the future as a neuroprotective molecule and preventing the deposition of various amyloid plaques and dysfunctional tau protein in the form of neurofibrillary tangles (Figure 1).